250 related articles for article (PubMed ID: 37845704)
1. A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice.
Feldman ECH; Homan KJ; Williams SE; Ting TV; Goldschneider KR; Kashikar-Zuck S
Pediatr Rheumatol Online J; 2023 Oct; 21(1):121. PubMed ID: 37845704
[TBL] [Abstract][Full Text] [Related]
2. Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome.
Kalisch L; Hamonet C; Bourdon C; Montalescot L; de Cazotte C; Baeza-Velasco C
Disabil Rehabil; 2020 Dec; 42(25):3679-3686. PubMed ID: 31060411
[No Abstract] [Full Text] [Related]
3. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
Teran-Wodzinski P; Kumar A
Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
[TBL] [Abstract][Full Text] [Related]
4. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
Thwaites PA; Gibson PR; Burgell RE
J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary chronic pain management strategies in patients with Ehlers-Danlos syndromes.
Gullapalli PA; Javed S
Pain Manag; 2023 Jan; 13(1):5-14. PubMed ID: 36305215
[TBL] [Abstract][Full Text] [Related]
6. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
Estrella E; Frazier PA
Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Symptoms, Dysautonomia, and Quality of Life in Adult and Pediatric Patients with Hypermobile Ehlers-Danlos Syndrome: A Brief Review.
Hertel A; Black WR; Malloy Walton L; Martin J; Jones J
Curr Cardiol Rev; 2024 Jan; 20(1):. PubMed ID: 38275067
[TBL] [Abstract][Full Text] [Related]
8. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA
Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648
[TBL] [Abstract][Full Text] [Related]
9. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.
Mu W; Muriello M; Clemens JL; Wang Y; Smith CH; Tran PT; Rowe PC; Francomano CA; Kline AD; Bodurtha J
Am J Med Genet A; 2019 Apr; 179(4):561-569. PubMed ID: 30703284
[TBL] [Abstract][Full Text] [Related]
11. Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.
Fernandez A; Jaquet M; Aubry-Rozier B; Suter M; Aybek S; Berna C
Brain Behav; 2024 Feb; 14(2):e3441. PubMed ID: 38409931
[TBL] [Abstract][Full Text] [Related]
12. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
Bennett SE; Walsh N; Moss T; Palmer S
Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
[TBL] [Abstract][Full Text] [Related]
13. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
Martin A
Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
[TBL] [Abstract][Full Text] [Related]
14. Clinical trajectory of hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders in older adults.
Anderson LK; Lane KR
J Am Assoc Nurse Pract; 2023 Oct; 35(10):605-612. PubMed ID: 37261967
[TBL] [Abstract][Full Text] [Related]
15. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
[TBL] [Abstract][Full Text] [Related]
16. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.
Engelbert RH; Juul-Kristensen B; Pacey V; de Wandele I; Smeenk S; Woinarosky N; Sabo S; Scheper MC; Russek L; Simmonds JV
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):158-167. PubMed ID: 28306230
[TBL] [Abstract][Full Text] [Related]
17. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
[TBL] [Abstract][Full Text] [Related]
18. Quantitative measures of tissue mechanics to detect hypermobile Ehlers-Danlos syndrome and hypermobility syndrome disorders: a systematic review.
Palmer S; Denner E; Riglar M; Scannell H; Webb S; Young G
Clin Rheumatol; 2020 Mar; 39(3):715-725. PubMed ID: 31955324
[TBL] [Abstract][Full Text] [Related]
19. Pediatric joint hypermobility: a diagnostic framework and narrative review.
Tofts LJ; Simmonds J; Schwartz SB; Richheimer RM; O'Connor C; Elias E; Engelbert R; Cleary K; Tinkle BT; Kline AD; Hakim AJ; van Rossum MAJ; Pacey V
Orphanet J Rare Dis; 2023 May; 18(1):104. PubMed ID: 37143135
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
